Minimally important differences of EORTC QLQ-C30 scales in patients with lung cancer or malignant pleural mesothelioma - Interpretation guidance derived from two randomized EORTC trials (vol 167C, pg 65, 2022)

被引：0
|
作者：
Koller, Michael [1 ]
Musoro, Jammbe Z. [2 ]
Tomaszewski, Krzysztof [3 ]
Coens, Corneel [2 ]
King, Madeleine T. [4 ]
Sprangers, Mirjam A. G. [5 ]
Groenvold, Mogens [6 ,7 ]
Cocks, Kim [8 ]
Velikova, Galina [9 ,10 ]
Flechtner, Hans-Henning [11 ]
Bottomley, Andrew
机构：
[1] Univ Hosp Regensburg, Ctr Clin Studies, Regensburg, Germany
[2] European Org Res & Treatment Canc EORTC, Brussels, Belgium
[3] Andrzej Frycz Modrzewski Krakow, Fac Med & Hlth Sci, Krakow, Poland
[4] Univ Sydney, Sch Psychol, Fac Sci, Sydney, NSW, Australia
[5] Amsterdam Univ Med Ctr, Dept Med Psychol, Amsterdam, Netherlands
[6] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark
[7] Bispebjerg Hosp, Copenhagen, Denmark
[8] Adelphi Values, Adelphi, Cheshire, England
[9] Univ Leeds, St Jamess Univ, Leeds Inst Med Res, Leeds, W Yorkshire, England
[10] St James Univ Hosp, Leeds Canc Ctr, Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England
[11] Univ Magdeburg, Clin Child & Adolescent Psychiat & Psychotherapy, Magdeburg, Germany
来源：
LUNG CANCER | 2022年 / 171卷
关键词：
D O I：
10.1016/j.lungcan.2022.05.006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：126 / 126
页数：1
相关论文
共 15 条
  • [1] Minimally important differences of EORTC QLQ-C30 scales in patients with lung cancer or malignant pleural mesothelioma-Interpretation guidance derived from two randomized EORTC trials
    Koller, Michael
    Musoro, Jammbe Z.
    Tomaszewski, Krzysztof
    Coens, Corneel
    King, Madeleine T.
    Sprangers, Mirjam A. G.
    Groenvold, Mogens
    Cocks, Kim
    Velikova, Galina
    Flechtner, Hans-Henning
    Bottomley, Andrew
    [J]. LUNG CANCER, 2022, 167 : 65 - 72
  • [2] Minimally important differences for the EORTC QLQ-C30 in prostate cancer clinical trials
    Eva M. Gamper
    Jammbe Z. Musoro
    Corneel Coens
    Jean-Jacques Stelmes
    Claudette Falato
    Mogens Groenvold
    Galina Velikova
    Kim Cocks
    Hans-Henning Flechtner
    Madeleine T. King
    Andrew Bottomley
    [J]. BMC Cancer, 21
  • [3] Minimally important differences for the EORTC QLQ-C30 in prostate cancer clinical trials
    Gamper, Eva M.
    Musoro, Jammbe Z.
    Coens, Corneel
    Stelmes, Jean-Jacques
    Falato, Claudette
    Groenvold, Mogens
    Velikova, Galina
    Cocks, Kim
    Flechtner, Hans-Henning
    King, Madeleine T.
    Bottomley, Andrew
    [J]. BMC CANCER, 2021, 21 (01)
  • [4] Minimally Important Differences for Interpreting EORTC QLQ-C30 Scores in Patients With Advanced Breast Cancer
    Musoro, Jammbe Z.
    Coens, Corneel
    Fiteni, Frederic
    Katarzyna, Pogoda
    Cardoso, Fatima
    Russell, Nicola S.
    King, Madeleine T.
    Cocks, Kim
    Sprangers, Mirjam Ag
    Groenvold, Mogens
    Velikova, Galina
    Flechtner, Hans-Henning
    Bottomley, Andrew
    [J]. JNCI CANCER SPECTRUM, 2019, 3 (03)
  • [5] Minimally important differences for interpreting the EORTC QLQ-C30 in patients with advanced colorectal cancer treated with chemotherapy
    Musoro, J. Z.
    Sodergren, S. C.
    Coens, C.
    Pochesci, A.
    Terada, M.
    King, M. T.
    Sprangers, M. A. G.
    Groenvold, M.
    Cocks, K.
    Velikova, G.
    Flechtner, H-H
    Bottomley, A.
    [J]. COLORECTAL DISEASE, 2020, 22 (12) : 2278 - 2287
  • [6] Minimal important differences of EORTC QLQ-C30 for metastatic breast cancer patients: Results from a randomized clinical trial
    Takuya Kawahara
    Naruto Taira
    Takeru Shiroiwa
    Yasuhiro Hagiwara
    Takashi Fukuda
    Yukari Uemura
    Hirofumi Mukai
    [J]. Quality of Life Research, 2022, 31 : 1829 - 1836
  • [7] Minimal important differences of EORTC QLQ-C30 for metastatic breast cancer patients: Results from a randomized clinical trial
    Kawahara, Takuya
    Taira, Naruto
    Shiroiwa, Takeru
    Hagiwara, Yasuhiro
    Fukuda, Takashi
    Uemura, Yukari
    Mukai, Hirofumi
    [J]. QUALITY OF LIFE RESEARCH, 2022, 31 (06) : 1829 - 1836
  • [8] Establishing anchor-based minimally important differences (MID) for the EORTC QLQ-C30 scales across multiple cancer sites
    Musoro, Jammbe Z.
    Coens, Corneel
    King, Madeleine
    Sprangers, Mirjam
    Groenvold, Mogens
    Cocks, Kim
    Velikova, Galina
    Singer, Susanne
    Oosting, Sjoukje
    Brandberg, Yvonne
    Cardoso, Fatima
    Pochesci, Alessia
    Terada, Mitsumi
    Stelmes, Jean-Jacques
    Frederic, Fiteni
    Katarzyna, Pogoda
    Reijneveld, Jaap
    Dirven, Linda
    Taphoorn, Martin
    Greimel, Elfriede
    Nordi, Andy
    van Dorst, Eleonora B. L.
    Bottomley, Andrew
    [J]. QUALITY OF LIFE RESEARCH, 2019, 28 : S65 - S66
  • [9] Synthesis of anchor-based minimally important differences (MID) for the EORTC QLQ-C30 scales across nine cancer sites
    Musoro, Jammbe Z.
    Coens, Corneel
    Sprangers, Mirjam A. G.
    Brandberg, Yvonne
    Groenvold, Mogens
    Cocks, Kim
    Velikova, Galina
    Dirven, Linda
    Greimel, Elfriede
    Singer, Susanne
    Katarzyna, Pogoda
    Gamper, Eva M.
    Sodergren, Samantha
    Eggermont, Alexander
    Koller, Michael
    King, Madeleine T.
    Bottomley, Andrew
    [J]. QUALITY OF LIFE RESEARCH, 2022, 31 : S47 - S48
  • [10] Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials
    Maringwa, John T.
    Quinten, Chantal
    King, Madeleine
    Ringash, Jolie
    Osoba, David
    Coens, Corneel
    Martinelli, Francesca
    Vercauteren, Jurgen
    Cleeland, Charles S.
    Flechtner, Henning
    Gotay, Carolyn
    Greimel, Eva
    Taphoorn, Martin J.
    Reeve, Bryce B.
    Schmucker-Von Koch, Joseph
    Weis, Joachim
    Smit, Egbert F.
    van Meerbeeck, Jan P.
    Bottomley, Andrew
    [J]. SUPPORTIVE CARE IN CANCER, 2011, 19 (11) : 1753 - 1760
12